Biocon unit to develop drugs with US firm | business | Hindustan Times
Today in New Delhi, India
Dec 08, 2016-Thursday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Biocon unit to develop drugs with US firm

business Updated: Mar 22, 2010 15:13 IST

Reuters
Highlight Story

Biocon said on Monday its unit, Syngene International, has entered into an agreement with Endo Pharmaceuticals USA to develop new cancer drugs.

Under the agreement, Endo will have all the rights to the drugs developed, while Syngene will receive research fees, milestone payments and success fees from Endo, it said in a statement.